Consecutive use of different biological therapies in the treatment of psoriasis


  • Conflicts of interest: A.C. acted as a paid speaker for MerkSerono. S.C. is a consultant and member of Advisory Boards and acted as a paid Speaker for Shering Plough and Whyet.

No abstract is available for this article.